Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene …
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Passage Bio, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Passage Bio, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Passage Bio, Inc..